COPD - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic inflammation of the airways leads to structural changes and narrowing, primarily due to long-term exposure to irritants like cigarette smoke. This inflammation results in mucus hypersecretion and ciliary dysfunction, impairing airway clearance.

• Secondary mechanism: Destruction of alveolar walls and loss of elastic recoil (emphysema) occur, reducing surface area for gas exchange and causing air trapping. This leads to hyperinflation of the lungs and increased work of breathing.

• Key complication: Persistent airflow limitation and impaired gas exchange result in hypoxemia and hypercapnia, which can lead to pulmonary hypertension and right-sided heart failure (cor pulmonale) if left unmanaged.

Patient Profile

Demographics:

68-year-old female, retired school teacher

History:

• Key past medical history: Chronic Obstructive Pulmonary Disease (COPD) diagnosed 5 years ago, hypertension, history of smoking (40 pack-years)

• Current medications: Tiotropium inhaler, Albuterol inhaler as needed, Lisinopril for hypertension

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing shortness of breath over the past week

• Key symptoms: Persistent cough with sputum production, fatigue, occasional wheezing, mild chest discomfort

• Vital signs: Blood pressure 150/90 mmHg, heart rate 98 bpm, respiratory rate 24 breaths per minute, oxygen saturation 89% on room air, temperature 37.2°C (99°F)

Section 1

As the healthcare team continues to monitor the 68-year-old female patient with COPD, several changes in her condition suggest developing complications. The patient's shortness of breath has intensified, and her oxygen saturation has further decreased to 86% on room air. Given these changes, supplemental oxygen is administered via nasal cannula at 2 liters per minute, which improves her saturation to 92%. However, her respiratory rate remains elevated at 26 breaths per minute, indicating persistent respiratory distress. Auscultation of the lungs reveals diffuse wheezing and crackles in the lower lung fields, suggesting possible exacerbation of her COPD and potential fluid accumulation.

A chest X-ray is ordered to further investigate the cause of her symptoms. The results reveal hyperinflated lungs, characteristic of COPD, but also show increased interstitial markings and mild cardiomegaly, raising suspicion of early right-sided heart failure (cor pulmonale). This aligns with her history of hypoxemia and the increased workload on the right side of the heart due to pulmonary hypertension. An echocardiogram is subsequently performed, confirming right ventricular hypertrophy and mild tricuspid regurgitation, indicative of strain on the heart.

In response to these findings, the healthcare team initiates a diuretic therapy to manage potential fluid overload and further discusses the need for optimizing her COPD management. Education on smoking cessation is reinforced, given her history of smoking, to prevent further progression of her pulmonary and cardiac conditions. Additionally, the team considers the potential need for long-term oxygen therapy and follows up with a pulmonologist to reassess and adjust her current treatment plan. The patient's response to these interventions will be closely monitored to prevent further complications and ensure improved quality of life.

Section 2

As the healthcare team continues to monitor the patient's response to the interventions, a scheduled follow-up assessment reveals notable changes in her condition. Despite the initiation of diuretic therapy, the patient exhibits signs of increased fatigue and reports episodes of dizziness upon standing. Her blood pressure is recorded at 90/58 mmHg, indicating hypotension likely secondary to diuretic use. This new development prompts the team to consider adjusting her medication regimen to balance fluid management without compromising hemodynamic stability.

Concurrently, the laboratory results return with elevated brain natriuretic peptide (BNP) levels, further confirming the presence of cardiac strain associated with right-sided heart failure. Arterial blood gas analysis shows a pH of 7.36, PaCO2 of 48 mmHg, and HCO3- of 28 mEq/L, suggestive of compensated respiratory acidosis, a common finding in COPD exacerbations. With these data, the team recognizes the importance of enhancing her respiratory support while cautiously managing her fluid status to prevent exacerbating her cardiac condition.

In light of these findings, the healthcare team decides to increase the patient's oxygen delivery to ensure adequate tissue perfusion and considers the introduction of a low-dose beta-blocker to manage heart failure symptoms without significantly impacting her respiratory status. They also schedule a multidisciplinary team meeting involving a cardiologist and pulmonologist to reassess her treatment plan and explore the possibility of more specialized care strategies, such as pulmonary rehabilitation, to address both her respiratory and cardiac needs. This collaborative approach aims to stabilize her condition, reduce hospital readmissions, and improve her overall quality of life.

Section 3

As the healthcare team implements the updated treatment plan, the patient initially shows signs of improvement in her respiratory function. However, during a routine bedside evaluation, the nurse notices increased jugular venous distention and mild peripheral edema, suggesting ongoing fluid retention despite diuretic therapy. The patient's oxygen saturation remains stable at 92% on 2L nasal cannula, but she continues to report persistent fatigue and occasional palpitations. A follow-up assessment of her vital signs reveals a heart rate of 110 beats per minute, indicating tachycardia, and blood pressure stabilizing slightly to 100/60 mmHg.

The team is concerned about the potential for worsening heart failure, so they decide to conduct an echocardiogram to assess her cardiac function more comprehensively. The results indicate mild to moderate right ventricular hypertrophy and an ejection fraction of 45%, confirming the strain on her heart due to chronic pulmonary hypertension associated with her COPD. These findings, coupled with the elevated BNP levels, underscore the need for careful titration of her medications to optimize both cardiac and respiratory function.

In response to these developments, the multidisciplinary team revisits her care plan, considering the introduction of an ACE inhibitor to further support cardiac output and reduce preload. They also discuss initiating a supervised pulmonary rehabilitation program to improve her exercise tolerance and overall functional status. The team recognizes the importance of ongoing monitoring and reevaluation to prevent further complications and ensure the patient's transition to a more stable and sustainable condition.

Section 4

Following the introduction of an ACE inhibitor, the patient initially demonstrates a slight improvement in her symptoms. Over the next few days, her heart rate decreases to 95 beats per minute, and her blood pressure stabilizes further at 105/65 mmHg. Her peripheral edema shows marginal reduction, and she reports feeling somewhat less fatigued, though she occasionally still experiences palpitations. The nursing team closely monitors her fluid status, electrolyte balance, and renal function due to the addition of the ACE inhibitor, ensuring that her blood urea nitrogen and creatinine levels remain within normal limits.

However, during a subsequent assessment, the nurse notes that the patient has developed a dry, persistent cough, a known side effect of ACE inhibitors. Furthermore, the patient's respiratory rate has increased slightly to 24 breaths per minute, and there is a subtle decrease in oxygen saturation to 90% on 2L nasal cannula. Given these developments, the healthcare team deliberates on modifying her medication regimen to balance the benefits of the ACE inhibitor with its adverse effects. They consider an ARB (angiotensin receptor blocker) as an alternative to mitigate the cough while continuing to support her cardiac function.

The team also emphasizes the importance of the pulmonary rehabilitation program, which the patient is scheduled to begin. The program aims to enhance her respiratory capacity, improve exercise tolerance, and ultimately contribute to better management of her COPD and associated cardiac conditions. As they proceed, the team remains vigilant in monitoring for any further complications, recognizing the need for a proactive and adaptive approach to her care plan to maintain her progress and prevent deterioration.

Section 5

A few days into the modified treatment plan, the patient returns for a follow-up assessment. The healthcare team notes a slight improvement in her respiratory symptoms after the switch from an ACE inhibitor to an ARB, with the dry cough noticeably less frequent. However, the patient's respiratory rate remains elevated at 22 breaths per minute, and her oxygen saturation fluctuates between 89% and 91% on the same 2L nasal cannula. The nurse observes mild respiratory distress, characterized by the use of accessory muscles and occasional wheezing upon auscultation. Despite these respiratory challenges, the patient's heart rate has stabilized further at 90 beats per minute, and her blood pressure is consistent at 100/60 mmHg, indicating a positive cardiac response to the ARB.

The healthcare team decides to conduct a series of diagnostic tests to better understand the underlying causes of her persistent respiratory issues. A repeat pulmonary function test reveals a slight decline in FEV1, suggesting a progression of her COPD. A chest X-ray is ordered, revealing increased lung hyperinflation and some evidence of pulmonary congestion, which raises concerns about possible cor pulmonale, a complication associated with COPD. Lab results show an increase in her white blood cell count to 12,000/mm³, hinting at a possible infection or inflammatory process that could be exacerbating her symptoms.

Recognizing the potential for a respiratory infection, the team initiates a course of antibiotics while reinforcing the importance of her upcoming pulmonary rehabilitation program. They stress the need to enhance her respiratory capacity and provide her with additional education on managing her COPD at home, including the use of bronchodilators and the importance of adhering to her medication regimen. The team remains vigilant, prepared to adjust her treatment plan as necessary based on her response to the current interventions and any new developments in her condition.